| PERIOD ENDING | 30-Jun-09 | 30-Jun-08 | 30-Jun-07 |
| Total Revenue | 503 | 554 | 1,879 |
| Cost of Revenue | 11 | 44 | 66 |
|
| Gross Profit | 492 | 510 | 1,812 |
|
| Operating Expenses |
| Research Development |
-
|
-
|
-
|
| Selling General and Administrative | 754 | 1,260 | 2,381 |
| Non Recurring |
-
|
-
| (8) |
| Others |
-
|
-
|
-
|
| |
| Total Operating Expenses |
-
|
-
|
-
|
|
|
| Operating Income or Loss | (262) | (750) | (561) |
|
| Income from Continuing Operations |
| Total Other Income/Expenses Net | 13 | 46 | 57 |
| Earnings Before Interest And Taxes | (248) | (704) | (504) |
| Interest Expense |
-
|
-
|
-
|
| Income Before Tax | (248) | (704) | (504) |
| Income Tax Expense |
-
|
-
|
-
|
| Minority Interest |
-
|
-
|
-
|
| |
| Net Income From Continuing Ops | (248) | (704) | (504) |
|
| Non-recurring Events |
| Discontinued Operations |
-
|
-
|
-
|
| Extraordinary Items |
-
|
-
|
-
|
| Effect Of Accounting Changes |
-
|
-
|
-
|
| Other Items |
-
|
-
|
-
|
|
|
| Net Income | (248) | (704) | (504) |
| Preferred Stock And Other Adjustments |
-
|
-
|
-
|
|
| Net Income Applicable To Common Shares | ($248) | ($704) | ($504) |
0.38% Nasdaq 
Income Statement
